New York, NY, March 01, 2016 -- Extreme Reach, the leader in TV and video convergence, announced today that Melinda McLaughlin has joined the company as Chief Marketing Officer. McLaughlin brings more than 25 years of marketing and brand building experience in the television and video advertising technology industries. She reports to Extreme Reach’s CEO, John Roland, and is a member of the company’s executive team.
|
|||||
“Melinda's unique combination of Agency, TV, and Digital Video experience, coupled with her strategic and creative expertise, make her a perfect fit for Extreme Reach,” said Roland. “We are delighted to have her on board to elevate awareness, differentiation, and adoption of the company’s enterprise platform.”
As the Chief Marketing Officer, Melinda spearheads all aspects of the company’s global marketing and communications and is building a team in New York and Needham, MA (company headquarters) that will raise the profile of Extreme Reach to all segments of the advertising ecosystem. In addition, Melinda will play a key role in driving market research, enabling sales, and setting product strategy mapped to market needs.
“The future for brand marketing is very bright as TV and video advertising rapidly converge in a content-everywhere world,” said McLaughlin. “Extreme Reach has the technology, the vision, and the team to make significant impact on a complex industry mired in workflow inefficiency. We connect all the steps of brand advertising previously unconnected and make it simple for our clients and their agencies to do business better, smarter and faster. I couldn’t be more excited to be here.”
McLaughlin was most recently CMO of Tremor Video, a video advertising technology company. In her five years in that role, she was instrumental in the growth of the brand from newcomer to major player. Prior to that she spent a decade at A+E Networks, leading teams in research, integrated sales, sales marketing, corporate marketing and creative services. Her career began with 15 years on the agency side where she led media planning and buying for a range of Fortune 500 corporations.
About Extreme Reach
Extreme Reach is the leading enterprise software platform for brand advertising management and execution that spans TV, Talent Rights Management, and Digital Video on any screen. Thousands of brands and agencies, including all of the Ad Age 100, look to Extreme Reach to activate, measure and optimize TV and video advertising campaigns in one platform. The Extreme Reach platform connects and simplifies workflows and unifying analytics. Extreme Reach is headquartered in Needham, Mass., with offices in 18 cities across the United States, Canada and the United Kingdom. For more information, visit extremereach.com.
http://www.globenewswire.com/NewsRoom/AttachmentNg/d402dcf2-24c1-4ad4-be70-7223807425ec
Sandy Drayton VP, Corporate Communications [email protected]


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



